Browse | MASI

Interactions between microbe and active substances

Therapeutic drugs
- A [Alimentary Tract And Metabolism] (230 drugs)
  - A01 [Stomatological Preparations] (16 drugs)
    - A01A [Stomatological Preparations] (16 drugs)
      - A01AB [Antiinfectives and antiseptics for local oral treatment] (12 drugs)
      - A01AC [Corticosteroids for local oral treatment] (3 drugs)
      - A01AD [Other agents for local oral treatment] (1 drugs)
  - A02 [Drugs For Acid Related Disorders] (63 drugs)
    - A02B [Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)] (63 drugs)
      - A02BA [H2-receptor antagonists] (8 drugs)
      - A02BB [Prostaglandins] (1 drugs)
      - A02BC [Proton pump inhibitors] (7 drugs)
      - A02BD [Combinations for eradication of Helicobacter pylori] (46 drugs)
      - A02BX [Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)] (1 drugs)
  - A03 [Drugs For Functional Gastrointestinal Disorders] (5 drugs)
    - A03A [Drugs For Functional Gastrointestinal Disorders] (4 drugs)
      - A03AA [Synthetic anticholinergics, esters with tertiary amino group] (1 drugs)
      - A03AD [Papaverine and derivatives] (1 drugs)
      - A03AE [Serotonin receptor antagonists] (1 drugs)
      - A03AX [Other drugs for functional gastrointestinal disorders] (1 drugs)
    - A03F [Propulsives] (1 drugs)
      - A03FA [Propulsives] (1 drugs)
  - A04 [Antiemetics And Antinauseants] (8 drugs)
    - A04A [Antiemetics And Antinauseants] (8 drugs)
      - A04AA [Serotonin (5HT3) antagonists] (5 drugs)
      - A04AD [Other antiemetics] (3 drugs)
  - A05 [Bile And Liver Therapy] (3 drugs)
    - A05A [Bile Therapy] (2 drugs)
      - A05AA [Bile acids and derivatives] (2 drugs)
    - A05B [Liver Therapy, Lipotropics] (1 drugs)
      - A05BA [Liver therapy] (1 drugs)
  - A06 [Drugs For Constipation] (15 drugs)
    - A06A [Drugs For Constipation] (15 drugs)
      - A06AB [Contact laxatives] (6 drugs)
      - A06AD [Osmotically acting laxatives] (4 drugs)
      - A06AG [Enemas] (3 drugs)
      - A06AH [Peripheral opioid receptor antagonists] (1 drugs)
      - A06AX [Other drugs for constipation] (1 drugs)
  - A07 [Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents] (31 drugs)
    - A07A [Intestinal Antiinfectives] (16 drugs)
      - A07AA [Antibiotics] (13 drugs)
      - A07AC [Imidazole derivatives] (1 drugs)
      - A07AX [Other intestinal antiinfectives] (2 drugs)
    - A07B [Intestinal Adsorbents] (1 drugs)
      - A07BC [Other intestinal adsorbents] (1 drugs)
    - A07D [Antipropulsives] (4 drugs)
      - A07DA [Antipropulsives] (4 drugs)
    - A07E [Intestinal Antiinflammatory Agents] (9 drugs)
      - A07EA [Corticosteroids acting locally] (5 drugs)
      - A07EC [Aminosalicylic acid and similar agents] (4 drugs)
    - A07X [Other Antidiarrheals] (1 drugs)
      - A07XA [Other antidiarrheals] (1 drugs)
  - A08 [Antiobesity Preparations, Excl. Diet Products] (4 drugs)
    - A08A [Antiobesity Preparations, Excl. Diet Products] (4 drugs)
      - A08AA [Centrally acting antiobesity products] (4 drugs)
  - A10 [Drugs Used In Diabetes] (71 drugs)
    - A10A [Insulins And Analogues] (6 drugs)
      - A10AB [Insulins and analogues for injection, fast-acting] (1 drugs)
      - A10AC [Insulins and analogues for injection, intermediate-acting] (1 drugs)
      - A10AD [Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting] (1 drugs)
      - A10AE [Insulins and analogues for injection, long-acting] (2 drugs)
      - A10AF [Insulins and analogues for inhalation] (1 drugs)
    - A10B [Blood Glucose Lowering Drugs, Excl. Insulins] (65 drugs)
      - A10BA [Biguanides] (2 drugs)
      - A10BB [Sulfonylureas] (9 drugs)
      - A10BD [Combinations of oral blood glucose lowering drugs] (39 drugs)
      - A10BF [Alpha glucosidase inhibitors] (3 drugs)
      - A10BG [Thiazolidinediones] (3 drugs)
      - A10BH [Dipeptidyl peptidase 4 (DPP-4) inhibitors] (6 drugs)
      - A10BJ [Glucagon-like peptide-1 (GLP-1) analogues] (1 drugs)
      - A10BX [Other blood glucose lowering drugs, excl. insulins] (2 drugs)
  - A11 [Vitamins] (7 drugs)
    - A11A [Multivitamins, Combinations] (1 drugs)
      - A11AA [Multivitamins with minerals] (1 drugs)
    - A11C [Vitamin A And D, Incl. Combinations Of The Two] (2 drugs)
      - A11CC [Vitamin D and analogues] (2 drugs)
    - A11G [Ascorbic Acid (Vitamin C), Incl. Combinations] (2 drugs)
      - A11GB [Ascorbic acid (vitamin C), combinations] (2 drugs)
    - A11H [Other Plain Vitamin Preparations] (2 drugs)
      - A11HA [Other plain vitamin preparations] (2 drugs)
  - A12 [Mineral Supplements] (3 drugs)
    - A12A [Calcium] (1 drugs)
      - A12AA [Calcium] (1 drugs)
    - A12C [Other Mineral Supplements] (2 drugs)
      - A12CA [Sodium] (1 drugs)
      - A12CB [Zinc] (1 drugs)
  - A14 [Anabolic Agents For Systemic Use] (1 drugs)
    - A14A [Anabolic Steroids] (1 drugs)
      - A14AA [Androstan derivatives] (1 drugs)
  - A16 [Other Alimentary Tract And Metabolism Products] (3 drugs)
    - A16A [Other Alimentary Tract And Metabolism Products] (3 drugs)
      - A16AA [Amino acids and derivatives] (1 drugs)
      - A16AX [Various alimentary tract and metabolism products] (2 drugs)
- B [Blood And Blood Forming Organs] (27 drugs)
  - B01 [Antithrombotic Agents] (9 drugs)
    - B01A [Antithrombotic Agents] (9 drugs)
      - B01AA [Vitamin K antagonists] (3 drugs)
      - B01AC [Platelet aggregation inhibitors excl. heparin] (6 drugs)
  - B02 [Antihemorrhagics] (3 drugs)
    - B02B [Vitamin K And Other Hemostatics] (3 drugs)
      - B02BA [Vitamin K] (1 drugs)
      - B02BX [Other systemic hemostatics] (2 drugs)
  - B03 [Antianemic Preparations] (4 drugs)
    - B03A [Iron Preparations] (2 drugs)
      - B03AE [Iron in other combinations] (2 drugs)
    - B03B [Vitamin B12 And Folic Acid] (2 drugs)
      - B03BB [Folic acid and derivatives] (2 drugs)
  - B05 [Blood Substitutes And Perfusion Solutions] (11 drugs)
    - B05B [I.V. Solutions] (1 drugs)
      - B05BA [Solutions for parenteral nutrition] (1 drugs)
    - B05C [Irrigating Solutions] (6 drugs)
      - B05CA [Antiinfectives] (4 drugs)
      - B05CX [Other irrigating solutions] (2 drugs)
    - B05X [I.V. Solution Additives] (4 drugs)
      - B05XA [Electrolyte solutions] (2 drugs)
      - B05XB [Amino acids] (2 drugs)
- C [Cardiovascular System] (296 drugs)
  - C01 [Cardiac Therapy] (23 drugs)
    - C01A [Cardiac Glycosides] (2 drugs)
      - C01AA [Digitalis glycosides] (2 drugs)
    - C01B [Antiarrhythmics, Class I And Iii] (9 drugs)
      - C01BA [Antiarrhythmics, class Ia] (5 drugs)
      - C01BB [Antiarrhythmics, class Ib] (1 drugs)
      - C01BC [Antiarrhythmics, class Ic] (1 drugs)
      - C01BD [Antiarrhythmics, class III] (2 drugs)
    - C01C [Cardiac Stimulants Excl. Cardiac Glycosides] (4 drugs)
      - C01CA [Adrenergic and dopaminergic agents] (3 drugs)
      - C01CX [Other cardiac stimulants] (1 drugs)
    - C01D [Vasodilators Used In Cardiac Diseases] (5 drugs)
      - C01DA [Organic nitrates] (4 drugs)
      - C01DX [Other vasodilators used in cardiac diseases] (1 drugs)
    - C01E [Other Cardiac Preparations] (3 drugs)
      - C01EB [Other cardiac preparations] (3 drugs)
  - C02 [Antihypertensives] (18 drugs)
    - C02A [Antiadrenergic Agents, Centrally Acting] (4 drugs)
      - C02AA [Rauwolfia alkaloids] (2 drugs)
      - C02AC [Imidazoline receptor agonists] (2 drugs)
    - C02C [Antiadrenergic Agents, Peripherally Acting] (1 drugs)
      - C02CA [Alpha-adrenoreceptor antagonists] (1 drugs)
    - C02D [Arteriolar Smooth Muscle, Agents Acting On] (2 drugs)
      - C02DA [Thiazide derivatives] (1 drugs)
      - C02DB [Hydrazinophthalazine derivatives] (1 drugs)
    - C02K [Other Antihypertensives] (4 drugs)
      - C02KX [Antihypertensives for pulmonary arterial hypertension] (4 drugs)
    - C02L [Antihypertensives And Diuretics In Combination] (7 drugs)
      - C02LA [Rauwolfia alkaloids and diuretics in combination] (3 drugs)
      - C02LC [Imidazoline receptor agonists in combination with diuretics] (2 drugs)
      - C02LE [Alpha-adrenoreceptor antagonists and diuretics] (1 drugs)
      - C02LG [Hydrazinophthalazine derivatives and diuretics] (1 drugs)
  - C03 [Diuretics] (30 drugs)
    - C03A [Low-Ceiling Diuretics, Thiazides] (11 drugs)
      - C03AA [Thiazides, plain] (4 drugs)
      - C03AB [Thiazides and potassium in combination] (4 drugs)
      - C03AH [Thiazides, combinations with psycholeptics and/or analgesics] (2 drugs)
      - C03AX [Thiazides, combinations with other drugs] (1 drugs)
    - C03B [Low-Ceiling Diuretics, Excl. Thiazides] (5 drugs)
      - C03BA [Sulfonamides, plain] (3 drugs)
      - C03BB [Sulfonamides and potassium in combination] (1 drugs)
      - C03BD [Xanthine derivatives] (1 drugs)
    - C03C [High-Ceiling Diuretics] (4 drugs)
      - C03CA [Sulfonamides, plain] (2 drugs)
      - C03CB [Sulfonamides and potassium in combination] (2 drugs)
    - C03D [Aldosterone Antagonists And Other Potassium-Sparing Agents] (3 drugs)
      - C03DA [Aldosterone antagonists] (1 drugs)
      - C03DB [Other potassium-sparing agents] (2 drugs)
    - C03E [Diuretics And Potassium-Sparing Agents In Combination] (6 drugs)
      - C03EA [Low-ceiling diuretics and potassium-sparing agents] (4 drugs)
      - C03EB [High-ceiling diuretics and potassium-sparing agents] (2 drugs)
    - C03X [Other Diuretics] (1 drugs)
      - C03XA [Vasopressin antagonists] (1 drugs)
  - C04 [Peripheral Vasodilators] (4 drugs)
    - C04A [Peripheral Vasodilators] (4 drugs)
      - C04AD [Purine derivatives] (1 drugs)
      - C04AE [Ergot alkaloids] (1 drugs)
      - C04AX [Other peripheral vasodilators] (2 drugs)
  - C05 [Vasoprotectives] (19 drugs)
    - C05A [Agents For Treatment Of Hemorrhoids And Anal Fissures For Topical Use] (13 drugs)
      - C05AA [Corticosteroids] (5 drugs)
      - C05AD [Local anesthetics] (1 drugs)
      - C05AE [Muscle relaxants] (3 drugs)
      - C05AX [Other agents for treatment of hemorrhoids and anal fissures for topical use] (4 drugs)
    - C05B [Antivaricose Therapy] (1 drugs)
      - C05BB [Sclerosing agents for local injection] (1 drugs)
    - C05C [Capillary Stabilizing Agents] (5 drugs)
      - C05CA [Bioflavonoids] (4 drugs)
      - C05CX [Other capillary stabilizing agents] (1 drugs)
  - C07 [Beta Blocking Agents] (38 drugs)
    - C07A [Beta Blocking Agents] (10 drugs)
      - C07AA [Beta blocking agents, non-selective] (5 drugs)
      - C07AB [Beta blocking agents, selective] (3 drugs)
      - C07AG [Alpha and beta blocking agents] (2 drugs)
    - C07B [Beta Blocking Agents And Thiazides] (9 drugs)
      - C07BA [Beta blocking agents, non-selective, and thiazides] (4 drugs)
      - C07BB [Beta blocking agents, selective, and thiazides] (4 drugs)
      - C07BG [Alpha and beta blocking agents and thiazides] (1 drugs)
    - C07C [Beta Blocking Agents And Other Diuretics] (2 drugs)
      - C07CB [Beta blocking agents, selective, and other diuretics] (1 drugs)
      - C07CG [Alpha and beta blocking agents and other diuretics] (1 drugs)
    - C07D [Beta Blocking Agents, Thiazides And Other Diuretics] (1 drugs)
      - C07DA [Beta blocking agents, non-selective, thiazides and other diuretics] (1 drugs)
    - C07F [Beta Blocking Agents, Other Combinations] (16 drugs)
      - C07FB [Beta blocking agents and calcium channel blockers] (8 drugs)
      - C07FX [Beta blocking agents, other combinations] (8 drugs)
  - C08 [Calcium Channel Blockers] (19 drugs)
    - C08C [Selective Calcium Channel Blockers With Mainly Vascular Effects] (13 drugs)
      - C08CA [Dihydropyridine derivatives] (13 drugs)
    - C08D [Selective Calcium Channel Blockers With Direct Cardiac Effects] (3 drugs)
      - C08DA [Phenylalkylamine derivatives] (2 drugs)
      - C08DB [Benzothiazepine derivatives] (1 drugs)
    - C08E [Non-Selective Calcium Channel Blockers] (1 drugs)
      - C08EX [Other non-selective calcium channel blockers] (1 drugs)
    - C08G [Calcium Channel Blockers And Diuretics] (2 drugs)
      - C08GA [Calcium channel blockers and diuretics] (2 drugs)
  - C09 [Agents Acting On The Renin-Angiotensin System] (79 drugs)
    - C09A [Ace Inhibitors, Plain] (8 drugs)
      - C09AA [ACE inhibitors, plain] (8 drugs)
    - C09B [Ace Inhibitors, Combinations] (25 drugs)
      - C09BA [ACE inhibitors and diuretics] (7 drugs)
      - C09BB [ACE inhibitors and calcium channel blockers] (11 drugs)
      - C09BX [ACE inhibitors, other combinations] (7 drugs)
    - C09C [Angiotensin Ii Receptor Blockers (Arbs), Plain] (6 drugs)
      - C09CA [Angiotensin II receptor blockers (ARBs), plain] (6 drugs)
    - C09D [Angiotensin Ii Receptor Blockers (Arbs), Combinations] (36 drugs)
      - C09DA [Angiotensin II receptor blockers (ARBs) and diuretics] (6 drugs)
      - C09DB [Angiotensin II receptor blockers (ARBs) and calcium channel blockers] (14 drugs)
      - C09DX [Angiotensin II receptor blockers (ARBs), other combinations] (16 drugs)
    - C09X [Other Agents Acting On The Renin-Angiotensin System] (4 drugs)
      - C09XA [Renin-inhibitors] (4 drugs)
  - C10 [Lipid Modifying Agents] (66 drugs)
    - C10A [Lipid Modifying Agents, Plain] (10 drugs)
      - C10AA [HMG CoA reductase inhibitors] (6 drugs)
      - C10AB [Fibrates] (3 drugs)
      - C10AX [Other lipid modifying agents] (1 drugs)
    - C10B [Lipid Modifying Agents, Combinations] (56 drugs)
      - C10BA [Combinations of various lipid modifying agents] (19 drugs)
      - C10BX [Lipid modifying agents in combination with other drugs] (37 drugs)
- D [Dermatologicals] (114 drugs)
  - D01 [Antifungals For Dermatological Use] (20 drugs)
    - D01A [Antifungals For Topical Use] (18 drugs)
      - D01AA [Antibiotics] (4 drugs)
      - D01AC [Imidazole and triazole derivatives] (10 drugs)
      - D01AE [Other antifungals for topical use] (4 drugs)
    - D01B [Antifungals For Systemic Use] (2 drugs)
      - D01BA [Antifungals for systemic use] (2 drugs)
  - D04 [Antipruritics, Incl. Antihistamines, Anesthetics, Etc.] (5 drugs)
    - D04A [Antipruritics, Incl. Antihistamines, Anesthetics, Etc.] (5 drugs)
      - D04AA [Antihistamines for topical use] (3 drugs)
      - D04AB [Anesthetics for topical use] (1 drugs)
      - D04AX [Other antipruritics] (1 drugs)
  - D05 [Antipsoriatics] (7 drugs)
    - D05A [Antipsoriatics For Topical Use] (4 drugs)
      - D05AC [Antracen derivatives] (2 drugs)
      - D05AD [Psoralens for topical use] (1 drugs)
      - D05AX [Other antipsoriatics for topical use] (1 drugs)
    - D05B [Antipsoriatics For Systemic Use] (3 drugs)
      - D05BA [Psoralens for systemic use] (1 drugs)
      - D05BB [Retinoids for treatment of psoriasis] (2 drugs)
  - D06 [Antibiotics And Chemotherapeutics For Dermatological Use] (20 drugs)
    - D06A [Antibiotics For Topical Use] (9 drugs)
      - D06AA [Tetracycline and derivatives] (3 drugs)
      - D06AX [Other antibiotics for topical use] (6 drugs)
    - D06B [Chemotherapeutics For Topical Use] (11 drugs)
      - D06BA [Sulfonamides] (6 drugs)
      - D06BB [Antivirals] (4 drugs)
      - D06BX [Other chemotherapeutics] (1 drugs)
  - D07 [Corticosteroids, Dermatological Preparations] (23 drugs)
    - D07A [Corticosteroids, Plain] (8 drugs)
      - D07AA [Corticosteroids, weak (group I)] (3 drugs)
      - D07AB [Corticosteroids, moderately potent (group II)] (2 drugs)
      - D07AC [Corticosteroids, potent (group III)] (3 drugs)
    - D07B [Corticosteroids, Combinations With Antiseptics] (3 drugs)
      - D07BA [Corticosteroids, weak, combinations with antiseptics] (2 drugs)
      - D07BC [Corticosteroids, potent, combinations with antiseptics] (1 drugs)
    - D07C [Corticosteroids, Combinations With Antibiotics] (6 drugs)
      - D07CA [Corticosteroids, weak, combinations with antibiotics] (3 drugs)
      - D07CB [Corticosteroids, moderately potent, combinations with antibiotics] (2 drugs)
      - D07CC [Corticosteroids, potent, combinations with antibiotics] (1 drugs)
    - D07X [Corticosteroids, Other Combinations] (6 drugs)
      - D07XA [Corticosteroids, weak, other combinations] (2 drugs)
      - D07XB [Corticosteroids, moderately potent, other combinations] (2 drugs)
      - D07XC [Corticosteroids, potent, other combinations] (2 drugs)
  - D08 [Antiseptics And Disinfectants] (15 drugs)
    - D08A [Antiseptics And Disinfectants] (15 drugs)
      - D08AC [Biguanides and amidines] (2 drugs)
      - D08AE [Phenol and derivatives] (3 drugs)
      - D08AF [Nitrofuran derivatives] (1 drugs)
      - D08AH [Quinoline derivatives] (2 drugs)
      - D08AK [Mercurial products] (3 drugs)
      - D08AL [Silver compounds] (1 drugs)
      - D08AX [Other antiseptics and disinfectants] (3 drugs)
  - D09 [Medicated Dressings] (5 drugs)
    - D09A [Medicated Dressings] (5 drugs)
      - D09AA [Medicated dressings with antiinfectives] (5 drugs)
  - D10 [Anti-Acne Preparations] (13 drugs)
    - D10A [Anti-Acne Preparations For Topical Use] (13 drugs)
      - D10AA [Corticosteroids, combinations for treatment of acne] (3 drugs)
      - D10AF [Antiinfectives for treatment of acne] (8 drugs)
      - D10AX [Other anti-acne preparations for topical use] (2 drugs)
  - D11 [Other Dermatological Preparations] (6 drugs)
    - D11A [Other Dermatological Preparations] (6 drugs)
      - D11AH [Agents for dermatitis, excluding corticosteroids] (1 drugs)
      - D11AX [Other dermatologicals] (5 drugs)
- G [Genito Urinary System And Sex Hormones] (179 drugs)
  - G01 [Gynecological Antiinfectives And Antiseptics] (68 drugs)
    - G01A [Antiinfectives And Antiseptics, Excl. Combinations With Corticosteroids] (68 drugs)
      - G01AA [Antibiotics] (8 drugs)
      - G01AC [Quinoline derivatives] (3 drugs)
      - G01AE [Sulfonamides] (35 drugs)
      - G01AF [Imidazole derivatives] (19 drugs)
      - G01AG [Triazole derivatives] (1 drugs)
      - G01AX [Other antiinfectives and antiseptics] (2 drugs)
  - G02 [Other Gynecologicals] (6 drugs)
    - G02A [Uterotonics] (1 drugs)
      - G02AD [Prostaglandins] (1 drugs)
    - G02B [Contraceptives For Topical Use] (1 drugs)
      - G02BB [Intravaginal contraceptives] (1 drugs)
    - G02C [Other Gynecologicals] (4 drugs)
      - G02CB [Prolactine inhibitors] (2 drugs)
      - G02CC [Antiinflammatory products for vaginal administration] (2 drugs)
  - G03 [Sex Hormones And Modulators Of The Genital System] (84 drugs)
    - G03A [Hormonal Contraceptives For Systemic Use] (20 drugs)
      - G03AA [Progestogens and estrogens, fixed combinations] (9 drugs)
      - G03AB [Progestogens and estrogens, sequential preparations] (6 drugs)
      - G03AC [Progestogens] (4 drugs)
      - G03AD [Emergency contraceptives] (1 drugs)
    - G03C [Estrogens] (11 drugs)
      - G03CA [Natural and semisynthetic estrogens, plain] (5 drugs)
      - G03CB [Synthetic estrogens, plain] (2 drugs)
      - G03CC [Estrogens, combinations with other drugs] (4 drugs)
    - G03D [Progestogens] (4 drugs)
      - G03DA [Pregnen (4) derivatives] (1 drugs)
      - G03DB [Pregnadien derivatives] (2 drugs)
      - G03DC [Estren derivatives] (1 drugs)
    - G03E [Androgens And Female Sex Hormones In Combination] (3 drugs)
      - G03EA [Androgens and estrogens] (3 drugs)
    - G03F [Progestogens And Estrogens In Combination] (39 drugs)
      - G03FA [Progestogens and estrogens, fixed combinations] (24 drugs)
      - G03FB [Progestogens and estrogens, sequential preparations] (15 drugs)
    - G03H [Antiandrogens] (3 drugs)
      - G03HA [Antiandrogens, plain] (1 drugs)
      - G03HB [Antiandrogens and estrogens] (2 drugs)
    - G03X [Other Sex Hormones And Modulators Of The Genital System] (4 drugs)
      - G03XA [Antigonadotropins and similar agents] (1 drugs)
      - G03XB [Progesterone receptor modulators] (2 drugs)
      - G03XC [Selective estrogen receptor modulators] (1 drugs)
  - G04 [Urologicals] (21 drugs)
    - G04B [Urologicals] (9 drugs)
      - G04BA [Acidifiers] (1 drugs)
      - G04BD [Drugs for urinary frequency and incontinence] (2 drugs)
      - G04BE [Drugs used in erectile dysfunction] (5 drugs)
      - G04BX [Other urologicals] (1 drugs)
    - G04C [Drugs Used In Benign Prostatic Hypertrophy] (12 drugs)
      - G04CA [Alpha-adrenoreceptor antagonists] (10 drugs)
      - G04CB [Testosterone-5-alpha reductase inhibitors] (2 drugs)
- H [Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins] (14 drugs)
  - H01 [Pituitary And Hypothalamic Hormones And Analogues] (1 drugs)
    - H01C [Hypothalamic Hormones] (1 drugs)
      - H01CC [Anti-gonadotropin-releasing hormones] (1 drugs)
  - H02 [Corticosteroids For Systemic Use] (9 drugs)
    - H02A [Corticosteroids For Systemic Use, Plain] (7 drugs)
      - H02AB [Glucocorticoids] (7 drugs)
    - H02B [Corticosteroids For Systemic Use, Combinations] (1 drugs)
      - H02BX [Corticosteroids for systemic use, combinations] (1 drugs)
    - H02C [Antiadrenal Preparations] (1 drugs)
      - H02CA [Anticorticosteroids] (1 drugs)
  - H03 [Thyroid Therapy] (3 drugs)
    - H03B [Antithyroid Preparations] (3 drugs)
      - H03BA [Thiouracils] (1 drugs)
      - H03BB [Sulfur-containing imidazole derivatives] (2 drugs)
  - H05 [Calcium Homeostasis] (1 drugs)
    - H05B [Anti-Parathyroid Agents] (1 drugs)
      - H05BX [Other anti-parathyroid agents] (1 drugs)
- J [Antiinfectives For Systemic Use] (350 drugs)
  - J01 [Antibacterials For Systemic Use] (211 drugs)
    - J01A [Tetracyclines] (16 drugs)
      - J01AA [Tetracyclines] (16 drugs)
    - J01B [Amphenicols] (3 drugs)
      - J01BA [Amphenicols] (3 drugs)
    - J01C [Beta-Lactam Antibacterials, Penicillins] (43 drugs)
      - J01CA [Penicillins with extended spectrum] (11 drugs)
      - J01CE [Beta-lactamase sensitive penicillins] (5 drugs)
      - J01CF [Beta-lactamase resistant penicillins] (6 drugs)
      - J01CG [Beta-lactamase inhibitors] (2 drugs)
      - J01CR [Combinations of penicillins, incl. beta-lactamase inhibitors] (19 drugs)
    - J01D [Other Beta-Lactam Antibacterials] (40 drugs)
      - J01DB [First-generation cephalosporins] (6 drugs)
      - J01DC [Second-generation cephalosporins] (11 drugs)
      - J01DD [Third-generation cephalosporins] (14 drugs)
      - J01DE [Fourth-generation cephalosporins] (2 drugs)
      - J01DF [Monobactams] (1 drugs)
      - J01DH [Carbapenems] (6 drugs)
    - J01E [Sulfonamides And Trimethoprim] (24 drugs)
      - J01EA [Trimethoprim and derivatives] (1 drugs)
      - J01EB [Short-acting sulfonamides] (6 drugs)
      - J01EC [Intermediate-acting sulfonamides] (3 drugs)
      - J01ED [Long-acting sulfonamides] (2 drugs)
      - J01EE [Combinations of sulfonamides and trimethoprim, incl. derivatives] (12 drugs)
    - J01F [Macrolides, Lincosamides And Streptogramins] (12 drugs)
      - J01FA [Macrolides] (10 drugs)
      - J01FF [Lincosamides] (2 drugs)
    - J01G [Aminoglycoside Antibacterials] (8 drugs)
      - J01GA [Streptomycins] (1 drugs)
      - J01GB [Other aminoglycosides] (7 drugs)
    - J01M [Quinolone Antibacterials] (23 drugs)
      - J01MA [Fluoroquinolones] (17 drugs)
      - J01MB [Other quinolones] (6 drugs)
    - J01R [Combinations Of Antibacterials] (26 drugs)
      - J01RA [Combinations of antibacterials] (26 drugs)
    - J01X [Other Antibacterials] (16 drugs)
      - J01XA [Glycopeptide antibacterials] (4 drugs)
      - J01XB [Polymyxins] (2 drugs)
      - J01XD [Imidazole derivatives] (3 drugs)
      - J01XE [Nitrofuran derivatives] (2 drugs)
      - J01XX [Other antibacterials] (5 drugs)
  - J02 [Antimycotics For Systemic Use] (12 drugs)
    - J02A [Antimycotics For Systemic Use] (12 drugs)
      - J02AA [Antibiotics] (1 drugs)
      - J02AB [Imidazole derivatives] (2 drugs)
      - J02AC [Triazole and tetrazole derivatives] (5 drugs)
      - J02AX [Other antimycotics for systemic use] (4 drugs)
  - J04 [Antimycobacterials] (33 drugs)
    - J04A [Drugs For Treatment Of Tuberculosis] (31 drugs)
      - J04AB [Antibiotics] (5 drugs)
      - J04AC [Hydrazides] (2 drugs)
      - J04AD [Thiocarbamide derivatives] (1 drugs)
      - J04AK [Other drugs for treatment of tuberculosis] (3 drugs)
      - J04AM [Combinations of drugs for treatment of tuberculosis] (20 drugs)
    - J04B [Drugs For Treatment Of Lepra] (2 drugs)
      - J04BA [Drugs for treatment of lepra] (2 drugs)
  - J05 [Antivirals For Systemic Use] (93 drugs)
    - J05A [Direct Acting Antivirals] (93 drugs)
      - J05AB [Nucleosides and nucleotides excl. reverse transcriptase inhibitors] (7 drugs)
      - J05AC [Cyclic amines] (1 drugs)
      - J05AE [Protease inhibitors] (9 drugs)
      - J05AF [Nucleoside and nucleotide reverse transcriptase inhibitors] (9 drugs)
      - J05AG [Non-nucleoside reverse transcriptase inhibitors] (4 drugs)
      - J05AH [Neuraminidase inhibitors] (2 drugs)
      - J05AJ [Integrase inhibitors] (2 drugs)
      - J05AP [Antivirals for treatment of HCV infections] (7 drugs)
      - J05AR [Antivirals for treatment of HIV infections, combinations] (49 drugs)
      - J05AX [Other antivirals] (3 drugs)
  - J06 [Immune Sera And Immunoglobulins] (1 drugs)
    - J06B [Immunoglobulins] (1 drugs)
      - J06BD [Antiviral monoclonal antibodies] (1 drugs)
- L [Antineoplastic And Immunomodulating Agents] (84 drugs)
  - L01 [Antineoplastic Agents] (55 drugs)
    - L01A [Alkylating Agents] (5 drugs)
      - L01AA [Nitrogen mustard analogues] (2 drugs)
      - L01AD [Nitrosoureas] (1 drugs)
      - L01AX [Other alkylating agents] (2 drugs)
    - L01B [Antimetabolites] (15 drugs)
      - L01BA [Folic acid analogues] (1 drugs)
      - L01BB [Purine analogues] (5 drugs)
      - L01BC [Pyrimidine analogues] (9 drugs)
    - L01C [Plant Alkaloids And Other Natural Products] (6 drugs)
      - L01CA [Vinca alkaloids and analogues] (2 drugs)
      - L01CB [Podophyllotoxin derivatives] (1 drugs)
      - L01CD [Taxanes] (1 drugs)
      - L01CE [Topoisomerase 1 (TOP1) inhibitors] (2 drugs)
    - L01D [Cytotoxic Antibiotics And Related Substances] (4 drugs)
      - L01DB [Anthracyclines and related substances] (4 drugs)
    - L01E [Protein Kinase Inhibitors] (8 drugs)
      - L01EA [BCR-ABL tyrosine kinase inhibitors] (2 drugs)
      - L01EB [Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors] (2 drugs)
      - L01EG [Mammalian target of rapamycin (mTOR) kinase inhibitors] (1 drugs)
      - L01EX [Other protein kinase inhibitors] (3 drugs)
    - L01F [Monoclonal Antibodies And Antibody Drug Conjugates] (2 drugs)
      - L01FF [PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors] (1 drugs)
      - L01FX [Other monoclonal antibodies and antibody drug conjugates] (1 drugs)
    - L01X [Other Antineoplastic Agents] (15 drugs)
      - L01XA [Platinum compounds] (3 drugs)
      - L01XB [Methylhydrazines] (1 drugs)
      - L01XF [Retinoids for cancer treatment] (1 drugs)
      - L01XH [Histone deacetylase (HDAC) inhibitors] (1 drugs)
      - L01XX [Other antineoplastic agents] (7 drugs)
      - L01XY [Combinations of antineoplastic agents] (2 drugs)
  - L02 [Endocrine Therapy] (13 drugs)
    - L02A [Hormones And Related Agents] (4 drugs)
      - L02AA [Estrogens] (2 drugs)
      - L02AB [Progestogens] (1 drugs)
      - L02AE [Gonadotropin releasing hormone analogues] (1 drugs)
    - L02B [Hormone Antagonists And Related Agents] (9 drugs)
      - L02BA [Anti-estrogens] (2 drugs)
      - L02BB [Anti-androgens] (3 drugs)
      - L02BG [Aromatase inhibitors] (3 drugs)
      - L02BX [Other hormone antagonists and related agents] (1 drugs)
  - L03 [Immunostimulants] (1 drugs)
    - L03A [Immunostimulants] (1 drugs)
      - L03AX [Other immunostimulants] (1 drugs)
  - L04 [Immunosuppressants] (15 drugs)
    - L04A [Immunosuppressants] (15 drugs)
      - L04AA [Selective immunosuppressants] (6 drugs)
      - L04AB [Tumor necrosis factor alpha (TNF-alpha) inhibitors] (3 drugs)
      - L04AC [Interleukin inhibitors] (1 drugs)
      - L04AD [Calcineurin inhibitors] (1 drugs)
      - L04AX [Other immunosuppressants] (4 drugs)
- M [Musculo-Skeletal System] (77 drugs)
  - M01 [Antiinflammatory And Antirheumatic Products] (34 drugs)
    - M01A [Antiinflammatory And Antirheumatic Products, Non-Steroids] (32 drugs)
      - M01AA [Butylpyrazolidines] (1 drugs)
      - M01AB [Acetic acid derivatives and related substances] (9 drugs)
      - M01AC [Oxicams] (3 drugs)
      - M01AE [Propionic acid derivatives] (12 drugs)
      - M01AG [Fenamates] (3 drugs)
      - M01AH [Coxibs] (1 drugs)
      - M01AX [Other antiinflammatory and antirheumatic agents, non-steroids] (3 drugs)
    - M01B [Antiinflammatory/Antirheumatic Agents In Combination] (1 drugs)
      - M01BA [Antiinflammatory/antirheumatic agents in combination with corticosteroids] (1 drugs)
    - M01C [Specific Antirheumatic Agents] (1 drugs)
      - M01CB [Gold preparations] (1 drugs)
  - M02 [Topical Products For Joint And Muscular Pain] (14 drugs)
    - M02A [Topical Products For Joint And Muscular Pain] (14 drugs)
      - M02AA [Antiinflammatory preparations, non-steroids for topical use] (13 drugs)
      - M02AB [Capsaicin and similar agents] (1 drugs)
  - M03 [Muscle Relaxants] (15 drugs)
    - M03B [Muscle Relaxants, Centrally Acting Agents] (14 drugs)
      - M03BA [Carbamic acid esters] (6 drugs)
      - M03BB [Oxazol, thiazine, and triazine derivatives] (6 drugs)
      - M03BX [Other centrally acting agents] (2 drugs)
    - M03C [Muscle Relaxants, Directly Acting Agents] (1 drugs)
      - M03CA [Dantrolene and derivatives] (1 drugs)
  - M04 [Antigout Preparations] (7 drugs)
    - M04A [Antigout Preparations] (7 drugs)
      - M04AA [Preparations inhibiting uric acid production] (3 drugs)
      - M04AB [Preparations increasing uric acid excretion] (3 drugs)
      - M04AC [Preparations with no effect on uric acid metabolism] (1 drugs)
  - M05 [Drugs For Treatment Of Bone Diseases] (6 drugs)
    - M05B [Drugs Affecting Bone Structure And Mineralization] (6 drugs)
      - M05BB [Bisphosphonates, combinations] (6 drugs)
  - M09 [Other Drugs For Disorders Of The Musculo-Skeletal System] (1 drugs)
    - M09A [Other Drugs For Disorders Of The Musculo-Skeletal System] (1 drugs)
      - M09AA [Quinine and derivatives] (1 drugs)
- N [Nervous System] (163 drugs)
  - N01 [Anesthetics] (5 drugs)
    - N01A [Anesthetics, General] (1 drugs)
      - N01AX [Other general anesthetics] (1 drugs)
    - N01B [Anesthetics, Local] (4 drugs)
      - N01BA [Esters of aminobenzoic acid] (1 drugs)
      - N01BB [Amides] (1 drugs)
      - N01BX [Other local anesthetics] (2 drugs)
  - N02 [Analgesics] (40 drugs)
    - N02A [Opioids] (27 drugs)
      - N02AA [Natural opium alkaloids] (7 drugs)
      - N02AG [Opioids in combination with antispasmodics] (1 drugs)
      - N02AJ [Opioids in combination with non-opioid analgesics] (16 drugs)
      - N02AX [Other opioids] (3 drugs)
    - N02B [Other Analgesics And Antipyretics] (10 drugs)
      - N02BA [Salicylic acid and derivatives] (4 drugs)
      - N02BE [Anilides] (6 drugs)
    - N02C [Antimigraine Preparations] (3 drugs)
      - N02CC [Selective serotonin (5HT1) agonists] (2 drugs)
      - N02CX [Other antimigraine preparations] (1 drugs)
  - N03 [Antiepileptics] (16 drugs)
    - N03A [Antiepileptics] (16 drugs)
      - N03AA [Barbiturates and derivatives] (1 drugs)
      - N03AB [Hydantoin derivatives] (2 drugs)
      - N03AD [Succinimide derivatives] (1 drugs)
      - N03AE [Benzodiazepine derivatives] (1 drugs)
      - N03AF [Carboxamide derivatives] (3 drugs)
      - N03AG [Fatty acid derivatives] (1 drugs)
      - N03AX [Other antiepileptics] (7 drugs)
  - N04 [Anti-Parkinson Drugs] (12 drugs)
    - N04A [Anticholinergic Agents] (2 drugs)
      - N04AA [Tertiary amines] (2 drugs)
    - N04B [Dopaminergic Agents] (10 drugs)
      - N04BA [Dopa and dopa derivatives] (3 drugs)
      - N04BB [Adamantane derivatives] (1 drugs)
      - N04BC [Dopamine agonists] (3 drugs)
      - N04BD [Monoamine oxidase B inhibitors] (1 drugs)
      - N04BX [Other dopaminergic agents] (2 drugs)
  - N05 [Psycholeptics] (39 drugs)
    - N05A [Antipsychotics] (18 drugs)
      - N05AA [Phenothiazines with aliphatic side-chain] (1 drugs)
      - N05AB [Phenothiazines with piperazine structure] (3 drugs)
      - N05AC [Phenothiazines with piperidine structure] (1 drugs)
      - N05AD [Butyrophenone derivatives] (2 drugs)
      - N05AE [Indole derivatives] (1 drugs)
      - N05AF [Thioxanthene derivatives] (1 drugs)
      - N05AG [Diphenylbutylpiperidine derivatives] (1 drugs)
      - N05AH [Diazepines, oxazepines, thiazepines and oxepines] (2 drugs)
      - N05AL [Benzamides] (1 drugs)
      - N05AX [Other antipsychotics] (5 drugs)
    - N05B [Anxiolytics] (9 drugs)
      - N05BA [Benzodiazepine derivatives] (6 drugs)
      - N05BC [Carbamates] (2 drugs)
      - N05BE [Azaspirodecanedione derivatives] (1 drugs)
    - N05C [Hypnotics And Sedatives] (12 drugs)
      - N05CA [Barbiturates, plain] (1 drugs)
      - N05CB [Barbiturates, combinations] (2 drugs)
      - N05CD [Benzodiazepine derivatives] (4 drugs)
      - N05CF [Benzodiazepine related drugs] (2 drugs)
      - N05CH [Melatonin receptor agonists] (1 drugs)
      - N05CM [Other hypnotics and sedatives] (1 drugs)
      - N05CX [Hypnotics and sedatives in combination, excl. barbiturates] (1 drugs)
  - N06 [Psychoanaleptics] (41 drugs)
    - N06A [Antidepressants] (24 drugs)
      - N06AA [Non-selective monoamine reuptake inhibitors] (9 drugs)
      - N06AB [Selective serotonin reuptake inhibitors] (5 drugs)
      - N06AF [Monoamine oxidase inhibitors, non-selective] (1 drugs)
      - N06AX [Other antidepressants] (9 drugs)
    - N06B [Psychostimulants, Agents Used For Adhd And Nootropics] (7 drugs)
      - N06BA [Centrally acting sympathomimetics] (4 drugs)
      - N06BC [Xanthine derivatives] (1 drugs)
      - N06BX [Other psychostimulants and nootropics] (2 drugs)
    - N06C [Psycholeptics And Psychoanaleptics In Combination] (2 drugs)
      - N06CA [Antidepressants in combination with psycholeptics] (2 drugs)
    - N06D [Anti-Dementia Drugs] (8 drugs)
      - N06DA [Anticholinesterases] (7 drugs)
      - N06DX [Other anti-dementia drugs] (1 drugs)
  - N07 [Other Nervous System Drugs] (10 drugs)
    - N07A [Parasympathomimetics] (1 drugs)
      - N07AX [Other parasympathomimetics] (1 drugs)
    - N07B [Drugs Used In Addictive Disorders] (4 drugs)
      - N07BA [Drugs used in nicotine dependence] (1 drugs)
      - N07BB [Drugs used in alcohol dependence] (2 drugs)
      - N07BC [Drugs used in opioid dependence] (1 drugs)
    - N07C [Antivertigo Preparations] (2 drugs)
      - N07CA [Antivertigo preparations] (2 drugs)
    - N07X [Other Nervous System Drugs] (3 drugs)
      - N07XX [Other nervous system drugs] (3 drugs)
- P [Antiparasitic Products, Insecticides And Repellents] (44 drugs)
  - P01 [Antiprotozoals] (29 drugs)
    - P01A [Agents Against Amoebiasis And Other Protozoal Diseases] (12 drugs)
      - P01AA [Hydroxyquinoline derivatives] (4 drugs)
      - P01AB [Nitroimidazole derivatives] (7 drugs)
      - P01AX [Other agents against amoebiasis and other protozoal diseases] (1 drugs)
    - P01B [Antimalarials] (14 drugs)
      - P01BB [Biguanides] (1 drugs)
      - P01BC [Methanolquinolines] (2 drugs)
      - P01BD [Diaminopyrimidines] (2 drugs)
      - P01BE [Artemisinin and derivatives, plain] (2 drugs)
      - P01BF [Artemisinin and derivatives, combinations] (7 drugs)
    - P01C [Agents Against Leishmaniasis And Trypanosomiasis] (3 drugs)
      - P01CC [Nitrofuran derivatives] (2 drugs)
      - P01CX [Other agents against leishmaniasis and trypanosomiasis] (1 drugs)
  - P02 [Anthelmintics] (10 drugs)
    - P02B [Antitrematodals] (2 drugs)
      - P02BA [Quinoline derivatives and related substances] (1 drugs)
      - P02BX [Other antitrematodal agents] (1 drugs)
    - P02C [Antinematodal Agents] (7 drugs)
      - P02CA [Benzimidazole derivatives] (4 drugs)
      - P02CC [Tetrahydropyrimidine derivatives] (1 drugs)
      - P02CE [Imidazothiazole derivatives] (1 drugs)
      - P02CF [Avermectines] (1 drugs)
    - P02D [Anticestodals] (1 drugs)
      - P02DA [Salicylic acid derivatives] (1 drugs)
  - P03 [Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents] (5 drugs)
    - P03A [Ectoparasiticides, Incl. Scabicides] (5 drugs)
      - P03AA [Sulfur containing products] (2 drugs)
      - P03AC [Pyrethrines, incl. synthetic compounds] (2 drugs)
      - P03AX [Other ectoparasiticides, incl. scabicides] (1 drugs)
- R [Respiratory System] (93 drugs)
  - R01 [Nasal Preparations] (16 drugs)
    - R01A [Decongestants And Other Nasal Preparations For Topical Use] (14 drugs)
      - R01AA [Sympathomimetics, plain] (2 drugs)
      - R01AB [Sympathomimetics, combinations excl. corticosteroids] (2 drugs)
      - R01AC [Antiallergic agents, excl. corticosteroids] (1 drugs)
      - R01AD [Corticosteroids] (8 drugs)
      - R01AX [Other nasal preparations] (1 drugs)
    - R01B [Nasal Decongestants For Systemic Use] (2 drugs)
      - R01BA [Sympathomimetics] (2 drugs)
  - R02 [Throat Preparations] (9 drugs)
    - R02A [Throat Preparations] (9 drugs)
      - R02AA [Antiseptics] (3 drugs)
      - R02AB [Antibiotics] (3 drugs)
      - R02AD [Anesthetics, local] (1 drugs)
      - R02AX [Other throat preparations] (2 drugs)
  - R03 [Drugs For Obstructive Airway Diseases] (49 drugs)
    - R03A [Adrenergics, Inhalants] (18 drugs)
      - R03AC [Selective beta-2-adrenoreceptor agonists] (3 drugs)
      - R03AK [Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics] (9 drugs)
      - R03AL [Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids] (6 drugs)
    - R03B [Other Drugs For Obstructive Airway Diseases, Inhalants] (4 drugs)
      - R03BA [Glucocorticoids] (3 drugs)
      - R03BX [Other drugs for obstructive airway diseases, inhalants] (1 drugs)
    - R03C [Adrenergics For Systemic Use] (4 drugs)
      - R03CA [Alpha- and beta-adrenoreceptor agonists] (1 drugs)
      - R03CC [Selective beta-2-adrenoreceptor agonists] (3 drugs)
    - R03D [Other Systemic Drugs For Obstructive Airway Diseases] (23 drugs)
      - R03DA [Xanthines] (14 drugs)
      - R03DB [Xanthines and adrenergics] (3 drugs)
      - R03DC [Leukotriene receptor antagonists] (4 drugs)
      - R03DX [Other systemic drugs for obstructive airway diseases] (2 drugs)
  - R05 [Cough And Cold Preparations] (3 drugs)
    - R05D [Cough Suppressants, Excl. Combinations With Expectorants] (3 drugs)
      - R05DA [Opium alkaloids and derivatives] (2 drugs)
      - R05DB [Other cough suppressants] (1 drugs)
  - R06 [Antihistamines For Systemic Use] (16 drugs)
    - R06A [Antihistamines For Systemic Use] (16 drugs)
      - R06AA [Aminoalkyl ethers] (6 drugs)
      - R06AD [Phenothiazine derivatives] (2 drugs)
      - R06AE [Piperazine derivatives] (1 drugs)
      - R06AX [Other antihistamines for systemic use] (7 drugs)
- S [Sensory Organs] (113 drugs)
  - S01 [Ophthalmologicals] (80 drugs)
    - S01A [Antiinfectives] (38 drugs)
      - S01AA [Antibiotics] (18 drugs)
      - S01AB [Sulfonamides] (4 drugs)
      - S01AD [Antivirals] (5 drugs)
      - S01AE [Fluoroquinolones] (8 drugs)
      - S01AX [Other antiinfectives] (3 drugs)
    - S01B [Antiinflammatory Agents] (14 drugs)
      - S01BA [Corticosteroids, plain] (5 drugs)
      - S01BB [Corticosteroids and mydriatics in combination] (4 drugs)
      - S01BC [Antiinflammatory agents, non-steroids] (5 drugs)
    - S01C [Antiinflammatory Agents And Antiinfectives In Combination] (13 drugs)
      - S01CA [Corticosteroids and antiinfectives in combination] (6 drugs)
      - S01CB [Corticosteroids/antiinfectives/mydriatics in combination] (5 drugs)
      - S01CC [Antiinflammatory agents, non-steroids and antiinfectives in combination] (2 drugs)
    - S01E [Antiglaucoma Preparations And Miotics] (6 drugs)
      - S01EA [Sympathomimetics in glaucoma therapy] (1 drugs)
      - S01EB [Parasympathomimetics] (2 drugs)
      - S01EC [Carbonic anhydrase inhibitors] (1 drugs)
      - S01ED [Beta blocking agents] (2 drugs)
    - S01F [Mydriatics And Cycloplegics] (4 drugs)
      - S01FA [Anticholinergics] (1 drugs)
      - S01FB [Sympathomimetics excl. antiglaucoma preparations] (3 drugs)
    - S01G [Decongestants And Antiallergics] (4 drugs)
      - S01GA [Sympathomimetics used as decongestants] (2 drugs)
      - S01GX [Other antiallergics] (2 drugs)
    - S01X [Other Ophthalmologicals] (1 drugs)
      - S01XA [Other ophthalmologicals] (1 drugs)
  - S02 [Otologicals] (19 drugs)
    - S02A [Antiinfectives] (12 drugs)
      - S02AA [Antiinfectives] (12 drugs)
    - S02B [Corticosteroids] (4 drugs)
      - S02BA [Corticosteroids] (4 drugs)
    - S02C [Corticosteroids And Antiinfectives In Combination] (3 drugs)
      - S02CA [Corticosteroids and antiinfectives in combination] (3 drugs)
  - S03 [Ophthalmological And Otological Preparations] (14 drugs)
    - S03A [Antiinfectives] (7 drugs)
      - S03AA [Antiinfectives] (7 drugs)
    - S03B [Corticosteroids] (3 drugs)
      - S03BA [Corticosteroids] (3 drugs)
    - S03C [Corticosteroids And Antiinfectives In Combination] (4 drugs)
      - S03CA [Corticosteroids and antiinfectives in combination] (4 drugs)
- V [Various] (18 drugs)
  - V03 [All Other Therapeutic Products] (10 drugs)
    - V03A [All Other Therapeutic Products] (10 drugs)
      - V03AB [Antidotes] (4 drugs)
      - V03AC [Iron chelating agents] (2 drugs)
      - V03AF [Detoxifying agents for antineoplastic treatment] (2 drugs)
      - V03AH [Drugs for treatment of hypoglycemia] (1 drugs)
      - V03AZ [Nerve depressants] (1 drugs)
  - V04 [Diagnostic Agents] (5 drugs)
    - V04C [Other Diagnostic Agents] (5 drugs)
      - V04CA [Tests for diabetes] (1 drugs)
      - V04CC [Tests for bile duct patency] (1 drugs)
      - V04CD [Tests for pituitary function] (1 drugs)
      - V04CG [Tests for gastric secretion] (1 drugs)
      - V04CX [Other diagnostic agents] (1 drugs)
  - V08 [Contrast Media] (3 drugs)
    - V08A [X-Ray Contrast Media, Iodinated] (3 drugs)
      - V08AB [Watersoluble, nephrotropic, low osmolar X-ray contrast media] (1 drugs)
      - V08AC [Watersoluble, hepatotropic X-ray contrast media] (2 drugs)

Browse all records in MASI database

Interactions between microbe and active substances